Show simple item record

dc.contributor.authorRamadi, Khalil B.
dc.contributor.authorMehta, Rhea
dc.contributor.authorHe, David
dc.contributor.authorChao, Sichen
dc.contributor.authorChu, Zen
dc.contributor.authorAtun, Rifat
dc.contributor.authorNguyen, Freddy T.
dc.date.accessioned2022-02-04T16:03:53Z
dc.date.available2022-02-04T16:03:53Z
dc.date.issued2022-01-21
dc.identifier.issn2398-6352
dc.identifier.urihttps://hdl.handle.net/1721.1/139849
dc.description.abstractAbstract The majority of biomedical research is funded by public, governmental, and philanthropic grants. These initiatives often shape the avenues and scope of research across disease areas. However, the prioritization of disease-specific funding is not always reflective of the health and social burden of each disease. We identify a prioritization disparity between lung and breast cancers, whereby lung cancer contributes to a substantially higher socioeconomic cost on society yet receives significantly less funding than breast cancer. Using search engine results and natural language processing (NLP) of Twitter tweets, we show that this disparity correlates with enhanced public awareness and positive sentiment for breast cancer. Interestingly, disease-specific venture activity does not correlate with funding or public opinion. We use outcomes from recent early-stage innovation events focused on lung cancer to highlight the complementary mechanism by which bottom-up “grass-roots” initiatives can identify and tackle under-prioritized conditions.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionof10.1038/s41746-021-00545-xen_US
dc.rightsCreative Commons Attribution 4.0 International licenseen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceNatureen_US
dc.titleGrass-roots entrepreneurship complements traditional top-down innovation in lung and breast canceren_US
dc.typeArticleen_US
dc.identifier.citationRamadi, K.B., Mehta, R., He, D. et al. Grass-roots entrepreneurship complements traditional top-down innovation in lung and breast cancer. npj Digit. Med. 5, 10 (2022)en_US
dc.contributor.departmentMassachusetts Institute of Technology. School of Engineering
dc.contributor.departmentSloan School of Management
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Science
dc.relation.journalnpj Digital Medicineen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.date.submission2022-02-04T15:47:00Z
mit.journal.volume5en_US
mit.journal.issue10en_US
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record